Scion Life Science

Scion Ventures prepares high-tech/bio-tech, green-tech/med-tech startups and selected non-profits for engagement with startup funding resources including F&F, angel investors and VCs by providing strategic guidance focused on securing seed capital and follow on funding.
Services for equity and/or pro-bono consulting services are available to start-ups pre-revenue.

Scion Life Sciences has made its debut as a venture firm, announcing the close of a $310 million fund to invest in new biotechnology startups. With its first fund, Scion aims to build “durable” biotech startups that can progress through testing independently. 

Scion initially planned to raise $250 million for its first fund but eventually pulled in another $60 million.